• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物源、内源性和合成大麻素:治疗乳腺癌和前列腺癌的有前景的化疗药物。

Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.

作者信息

Fraguas-Sánchez A I, Fernández-Carballido A, Torres-Suárez A I

机构信息

a Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy , Complutense University of Madrid , Madrid , Spain.

b Institute of Industrial Pharmacy , Complutense University of Madrid , Madrid , Spain.

出版信息

Expert Opin Investig Drugs. 2016 Nov;25(11):1311-1323. doi: 10.1080/13543784.2016.1236913. Epub 2016 Sep 28.

DOI:10.1080/13543784.2016.1236913
PMID:27633508
Abstract

The term 'cannabinoids' designates a family of compounds with activity upon cannabinoid receptors. Cannabinoids are classified in three groups: phytocannabinoids, endocannabinoids, and the synthetic analogues of both groups. They have become a promising tool in the treatment of cancer disease, not only as palliative agents, but also as antitumor drugs, due to their ability to inhibit the proliferation, adhesion, migration, invasion, and angiogenesis of tumour cells. Two of the cancers where they have shown high anticancer activity are breast and prostate tumours. Despite this potential clinical interest, several studies have also reported that cannabinoids can stimulate the proliferation of cancer cells at very low concentrations. Areas covered: The aim of this review is to evaluate the promising chemotherapeutic utility of phytocannabinoids, endocannabinoids, and synthetic cannabinoids in breast and prostate cancer. Expert opinion: Cannabinoids, in particular the non-psychoactive CBD, may be promising tools in combination therapy for breast and prostate cancer, due to their direct antitumor effects, their ability to improve the efficacy of conventional antitumor drugs and their usefulness as palliative treatment. Nevertheless, deeper studies to fully establish the mechanisms responsible for their antitumour and pro-tumour properties and their formulation in efficient delivery systems remain to be established.

摘要

术语“大麻素”指的是一类对大麻素受体具有活性的化合物。大麻素分为三类:植物大麻素、内源性大麻素以及这两类的合成类似物。由于它们具有抑制肿瘤细胞增殖、黏附、迁移、侵袭和血管生成的能力,大麻素已成为治疗癌症的一种有前景的工具,不仅可作为姑息治疗药物,还可作为抗肿瘤药物。它们已显示出高抗癌活性的两种癌症是乳腺癌和前列腺癌。尽管有这种潜在的临床价值,但也有几项研究报告称,大麻素在极低浓度下可刺激癌细胞增殖。涵盖领域:本综述的目的是评估植物大麻素、内源性大麻素和合成大麻素在乳腺癌和前列腺癌中有前景的化疗效用。专家观点:大麻素,尤其是无精神活性的大麻二酚(CBD),可能是乳腺癌和前列腺癌联合治疗中有前景的工具,这是由于它们的直接抗肿瘤作用、提高传统抗肿瘤药物疗效的能力以及作为姑息治疗的效用。然而,仍需进行更深入的研究,以全面确定其抗肿瘤和促肿瘤特性的机制,以及在高效递送系统中的制剂。

相似文献

1
Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.植物源、内源性和合成大麻素:治疗乳腺癌和前列腺癌的有前景的化疗药物。
Expert Opin Investig Drugs. 2016 Nov;25(11):1311-1323. doi: 10.1080/13543784.2016.1236913. Epub 2016 Sep 28.
2
Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER breast cancer cells: Impact on aromatase and steroid receptors.揭示大麻素在 ER 乳腺癌细胞中抗癌特性背后的作用机制:对芳香酶和类固醇受体的影响。
J Steroid Biochem Mol Biol. 2021 Jun;210:105876. doi: 10.1016/j.jsbmb.2021.105876. Epub 2021 Mar 17.
3
Cannabinoids as anticancer drugs: current status of preclinical research.大麻素类药物作为抗癌药物:临床前研究的现状。
Br J Cancer. 2022 Jul;127(1):1-13. doi: 10.1038/s41416-022-01727-4. Epub 2022 Mar 11.
4
Cannabinoids as Anticancer Drugs.大麻素作为抗癌药物。
Adv Pharmacol. 2017;80:397-436. doi: 10.1016/bs.apha.2017.04.002. Epub 2017 Jun 12.
5
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.大麻素和ω-3/6 内源性大麻素作为细胞死亡和抗癌调节剂。
Prog Lipid Res. 2013 Jan;52(1):80-109. doi: 10.1016/j.plipres.2012.10.001. Epub 2012 Oct 26.
6
The endocannabinoid system and cancer: therapeutic implication.内源性大麻素系统与癌症:治疗意义。
Br J Pharmacol. 2011 Aug;163(7):1447-63. doi: 10.1111/j.1476-5381.2011.01327.x.
7
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.植物源非精神活性大麻素的抗肿瘤活性
J Neuroimmune Pharmacol. 2015 Jun;10(2):255-67. doi: 10.1007/s11481-015-9608-y. Epub 2015 Apr 28.
8
Endocannabinoids and Cancer.内源性大麻素与癌症
Handb Exp Pharmacol. 2015;231:449-72. doi: 10.1007/978-3-319-20825-1_16.
9
Antitumorigenic targets of cannabinoids - current status and implications.大麻素的抗肿瘤靶点——现状与启示
Expert Opin Ther Targets. 2016 Oct;20(10):1219-35. doi: 10.1080/14728222.2016.1177512. Epub 2016 May 11.
10
Targeting the endocannabinoid system for the treatment of cancer--a practical view.针对癌症的内源性大麻素系统治疗——一种实用观点。
Curr Top Med Chem. 2010;10(8):814-27. doi: 10.2174/156802610791164201.

引用本文的文献

1
Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release.聚己内酯微球用于大麻二酚的皮下给药:体外和体内释放。
Drug Deliv Transl Res. 2024 Apr;14(4):959-969. doi: 10.1007/s13346-023-01444-2. Epub 2023 Oct 12.
2
Synthetic Pathways to Non-Psychotropic Phytocannabinoids as Promising Molecules to Develop Novel Antibiotics: A Review.非精神活性植物大麻素作为开发新型抗生素的有前景分子的合成途径:综述
Pharmaceutics. 2023 Jul 5;15(7):1889. doi: 10.3390/pharmaceutics15071889.
3
Phytochemical Constituents and Derivatives of Bridging the Gap in Melanoma Treatment.
bridging the gap in melanoma treatment 中 bridgin 的意思
Int J Mol Sci. 2023 Jan 3;24(1):859. doi: 10.3390/ijms24010859.
4
Improved Therapeutic Efficacy of CBD with Good Tolerance in the Treatment of Breast Cancer through Nanoencapsulation and in Combination with 20(S)-Protopanaxadiol (PPD).通过纳米包封并与20(S)-原人参二醇(PPD)联合使用,大麻二酚(CBD)在治疗乳腺癌方面具有更高的治疗效果且耐受性良好。
Pharmaceutics. 2022 Jul 22;14(8):1533. doi: 10.3390/pharmaceutics14081533.
5
Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype.大麻素类物质在乳腺癌中的作用:根据亚型的不同存在差异性敏感性。
Molecules. 2021 Dec 28;27(1):156. doi: 10.3390/molecules27010156.
6
Cannabinoid receptors promote chronic intermittent hypoxia-induced breast cancer metastasis via IGF-1R/AKT/GSK-3β.大麻素受体通过胰岛素样生长因子-1受体/蛋白激酶B/糖原合成酶激酶-3β促进慢性间歇性缺氧诱导的乳腺癌转移。
Mol Ther Oncolytics. 2021 Oct 1;23:220-230. doi: 10.1016/j.omto.2021.09.007. eCollection 2021 Dec 17.
7
Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease.内源性大麻素系统对代谢途径的功能微调——对健康和疾病的影响。
Int J Mol Sci. 2021 Apr 1;22(7):3661. doi: 10.3390/ijms22073661.
8
Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29).大麻素的药理作用不仅仅是缓解作用:CB2 大麻素受体激动剂诱导人结直肠癌细胞(HT-29)的细胞毒性和细胞凋亡。
Mol Cell Biochem. 2021 Sep;476(9):3285-3301. doi: 10.1007/s11010-021-04158-6. Epub 2021 Apr 22.
9
Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models.大麻素和合成大麻素在临床实验模型中的新兴作用。
Adv Exp Med Biol. 2021;1264:47-65. doi: 10.1007/978-3-030-57369-0_4.
10
The Interplay between Cancer Biology and the Endocannabinoid System-Significance for Cancer Risk, Prognosis and Response to Treatment.癌症生物学与内源性大麻素系统之间的相互作用——对癌症风险、预后及治疗反应的意义
Cancers (Basel). 2020 Nov 5;12(11):3275. doi: 10.3390/cancers12113275.